Serum Proteomics Service
MtoZ Biolabs provides LC-MS/MS serum proteomics for protein identification, relative quantification, and comparative research.
From sample assessment to bioinformatics, we help researchers compare serum protein profiles across study groups and explore candidates for further investigation.
- High-Resolution LC-MS/MS for Serum Protein Identification.
- Relative Quantification and Comparisons Across Sample Groups.
- Bioinformatics Analysis with Traceable Research Deliverables.
What Is Serum Proteomics?
Serum is the liquid remaining after whole blood clots and the clot and cells are removed. It contains albumin, immunoglobulins, and other circulating proteins whose abundance may change with physiological conditions, disease progression, or interventions. Unlike plasma collected with anticoagulants, serum differs in certain coagulation-related proteins. The same sample matrix should therefore be used for between-group comparisons whenever possible.
Serum proteomics primarily uses liquid chromatography-tandem mass spectrometry (LC-MS/MS) to identify detectable serum proteins and assess changes in their relative abundance. Statistical analysis and functional annotation help identify differentially abundant proteins and generate leads for follow-up research. Because serum proteins span a wide abundance range, consistent sample processing and an appropriate analytical strategy influence detection coverage, cross-sample comparability, and the interpretation of quantitative results.
When Serum Proteomics Is a Good Fit
Serum proteomics supports discovery-oriented comparisons of protein profiles when specific targets are not yet established. With clear research questions and appropriate groups, common research needs include:
lIdentifying Disease- or Phenotype-Associated Changes: Compare disease and control groups or phenotypes to identify differentially abundant proteins and prioritize candidates.
lEvaluating Intervention-Associated Protein Responses: Compare serum protein profiles before and after treatment or across experimental conditions to assess associated changes.
lComparing Animal Models and Cohorts: Examine protein trends across model groups, cohorts, or time points related to disease progression or experimental endpoints.
lSelecting Candidates for Subsequent Validation: Prioritize proteins for PRM or other validation based on peptide evidence, between-group differences, and biological relevance.
Archived cohorts, unusual species, or inconsistently stored samples require feasibility assessment based on available records. Studies focused on a few known proteins may be better suited to targeted analysis..
Serum Proteomics Service at MtoZ Biolabs
MtoZ Biolabs provides serum protein identification, relative quantification, and bioinformatics analysis using high-resolution LC-MS/MS. Acquisition strategies are selected according to research objectives, with protein lists, quantitative results, and reports supporting comparative studies.
lProtein Identification: Identify detectable proteins and peptides to characterize serum protein composition.
lRelative Quantification: Generate relative abundance matrices and compare proteins between study groups.
lBioinformatics: Perform appropriate sample-level statistics and functional annotation where suitable databases are available.
Additional options include serum/plasma PTM analysis, such as phosphorylation and glycosylation, and biomarker validation. These projects are evaluated separately because result consistency may differ from routine quantitative proteomics.
Choose the Right Serum Proteomics Workflow
Serum proteomics is not limited to a single acquisition method. The choice of analytical strategy primarily depends on whether cross-sample quantification is required, whether protein identification is the main objective, and whether the study has progressed to the candidate protein validation stage.
|
Analytical Strategy |
Suitable Research Needs |
Main Results and Selection Considerations |
|
Relative quantification and differential comparisons across serum sample groups |
Supports cross-sample abundance matrices and between-group statistics for discovery-oriented quantification. |
|
|
Complex serum peptides requiring ion mobility-assisted separation |
Adds ion mobility information to DIA; selection depends on objectives and platform. |
|
|
Protein identification or DDA-based label-free relative quantification |
DDA is an acquisition mode; LFQ is a quantification approach applied to the data. |
|
|
Targeted investigation of candidate proteins |
Evaluate target peptides and sample conditions. Absolute quantification requires an internal standard strategy. |
|
|
Multiplexed relative quantification across sample groups |
Supports relative abundance comparisons across labeled samples. Sample grouping and labeling design should be confirmed during project planning |
Experimental Instruments
Serum peptides are separated by nano-flow liquid chromatography and analyzed by high-resolution mass spectrometry. Platform configuration depends on the analytical strategy.
|
Instrument Category |
Representative Platforms |
Main Functions in Serum Proteomics |
|
Nano-Flow Liquid Chromatography (nanoLC) |
Vanquish Neo; UltiMate 3000 RSLCnano |
Separates complex serum peptides for mass spectrometry acquisition. |
|
High-Resolution Orbitrap Mass Spectrometry |
Orbitrap Exploris 480; Orbitrap Fusion Lumos |
Acquires high-resolution data for protein identification and strategies including DIA and DDA. |
|
Ion Mobility Mass Spectrometry |
timsTOF Series |
Provides ion mobility-assisted peptide separation and supports 4D-DIA where appropriate. |
Analysis Workflow
1. Sample Assessment and Study Design
Confirm species, sample type, groups, and storage records. Assess sample volume, hemolysis, lipemia, and other factors before selecting acquisition and comparison strategies.
2. Protein Processing and Digestion
Process serum proteins, perform necessary cleanup, and digest proteins enzymatically. SP3 magnetic-bead pretreatment can improve low-abundance protein detection without removing high-abundance proteins.
3. LC-MS/MS Acquisition
Separate peptides by liquid chromatography and acquire spectra using the selected DIA, 4D-DIA, DDA, or other appropriate strategy with acquisition quality control.
4. Protein Identification and Quantification
Identify and quantify peptides and proteins, and assess data quality using species-specific databases such as UniProt or client-provided FASTA files.
5. Statistical Analysis and Reporting
Conduct applicable PCA, differential protein analysis, and functional annotation. Compile QC metrics, quantitative matrices, figures, and raw data in a research report.

Figure 1. Serum Proteomics Workflow.
Sample Submission Requirements
Consistent serum collection, storage, and grouping support reliable comparisons. Submit sample information to allow assessment of analytical feasibility and study design.
|
Item |
Submission Recommendations and Information to Be Confirmed |
|
Sample Scope |
Human and common animal serum samples are routinely accepted. Other species can be evaluated when a reference protein database for the same or a closely related species is available. Disease samples, drug-treated samples, and clinical cohort samples are routinely accepted. |
|
Collection and Separation |
Use a serum collection tube without anticoagulant (red-top recommended; consult the technical team before using other tubes). Gently invert 8-10 times and let stand at 4°C for 30 min. Centrifuge at 4°C and 1,000 × g for 10 min; transfer the upper serum, mix, and briefly centrifuge. Aliquot 100-200 μL per tube. |
|
Sample Amount |
For routine and deep serum proteomics, confirm the required sample volume with the technical team before submission. For PTM analysis, a starting volume of at least 100 μL is recommended. For PRM validation, the minimum sample volume is 20-50 μL, with 50-100 μL recommended; protein input is at least 50 μg, with 100 μg recommended. |
|
Storage and Transportation |
Store at −80°C or in liquid nitrogen and ship on dry ice. Keep freeze-thaw cycles to 2-3 or fewer and record the number of previous cycles. |
|
Abnormal Samples |
Obvious hemolysis, severe lipemia, icterus, precipitation, or degradation require evaluation. Assess hyperlipidemia-related studies according to research objectives. |
|
Sample Information |
Provide sample IDs, species, groups, and collection and storage records. At least 3 biological replicates per group are required. For clinical cohorts, 10-30 samples per group are recommended; for model-animal studies, 6-10 samples per group are recommended. |
For infectious or biosafety-sensitive samples, provide any required documentation of compliant inactivation and confirm acceptance conditions before submission.

Figure 2. Sample Submission Checklist.
Why Choose MtoZ Biolabs?
1. High-Resolution Mass Spectrometry
MtoZ Biolabs uses high-resolution Orbitrap mass spectrometry to acquire peptide data for serum protein identification and relative quantification.
2. Customized Proteomics Solutions
MtoZ Biolabs tailors analytical strategies to research objectives, sample numbers, species, and identification or quantification requirements.
3. Experienced Scientific Team
MtoZ Biolabs brings expertise in mass spectrometry, proteomics, and bioinformatics to technically demanding serum projects.
4. Integrated Multi-Omics Capabilities
MtoZ Biolabs combines proteomics, metabolomics, and bioinformatics services to support cross-omics and follow-up research.
5. One-Time Charge
Our pricing is transparent, with no hidden fees or additional costs.
Applications
1. Disease Mechanism and Biomarker Discovery
Compare disease groups, clinical subgroups, or phenotypes to identify proteins associated with inflammation, immune regulation, or metabolism. Findings can guide mechanistic and biomarker research, but candidates require validation in independent samples.
2. Drug Response and Intervention Studies
Assess serum protein changes across treatments, doses, or other interventions to explore associated pathways and systemic responses. Consider sampling times and experimental endpoints when interpreting results.
3. Animal Models and Longitudinal Research
Track serum protein changes across animal model stages or longitudinal sampling alongside tissue phenotypes or disease progression. Preserve individual sample associations and sampling records.
4. Multi-Omics Research
Integrate serum proteomics with metabolomics or other omics to examine shared molecular and pathway changes. Correlation does not establish causation.
Deliverables
Deliverables depend on study groups and the analytical strategy. Typical outputs include:
lProtein Identification: Protein and peptide identification lists with relevant annotations.
lQuantitative Results: Relative abundance matrices and differential protein results where the design permits.
lStatistics and Bioinformatics: Applicable sample correlations, PCA, clustering, volcano plots, GO, KEGG, Reactome, and protein-protein interaction (PPI) analysis.
lQuality Control and Raw Data: Mass spectrometry QC metrics, including peptide length and identification scores, raw files, analytical results, and a technical report.
Client-provided FASTA files can be used for custom protein searches. When a client-provided FASTA is used, GO, KEGG, Reactome, and PPI analyses are not included by default.
FAQ
Q1: Can Serum and Plasma Samples Be Combined for Between-Group Comparisons?
Both serum and plasma can be analyzed. If both can be prepared, plasma is recommended. If both matrices have already been collected, matrix-related differences should be considered in the study design and interpretation.
Q2: Can Routine Serum Proteomics Detect All Low-Abundance Proteins?
Not all low-abundance proteins can be detected. Serum contains proteins across a wide abundance range, and abundant proteins can mask low-abundance peptides.
Q3: Can Serum Samples Stored for Extended Periods Still Be Analyzed?
Samples stored at −80°C or in liquid nitrogen without freeze-thaw may remain suitable for approximately 6 months to 2 years. Suitability should still be assessed based on storage records, sample appearance, and consistency between groups.
Q4: How Can Candidate Proteins Be Validated After Discovery-Oriented Analysis?
Select candidates based on differential changes, peptide evidence, and cross-sample consistency. Depending on the target, consider PRM or orthogonal validation. Absolute quantification requires a separately evaluated internal standard strategy.
Start Your Project with MtoZ Biolabs
Contact the MtoZ Biolabs technical team to discuss research objectives, sample sources, species, grouping, storage conditions, and suitable analytical strategies for serum proteomics project design.
MtoZ Biolabs, an integrated chromatography and mass spectrometry (MS) services provider.
Related Services
Mitochondrial Proteomics Service